Biotechnology Novo Nordisk Sets Timeframe For Its Next-Gen Experimental Obesity Drug – Novo Nordisk (NYSE:NVO) Read more
Cannabis Cannabis With Ozempic, Wegovy, Other Weight-Loss Drugs: Here’s What You Need To Know If You’re Combining Them – Novo Nordisk (NYSE:NVO) Read more
Stockmarkets Novo Nordisk expects Catalent deal to close later this year Reuters via biedexmarkets.com Read more
Biotechnology Novo Nordisk’s Stock Hits 52-Week High After Highly Sought After Obesity Drug Trial Data Why Novo Nordisk Stock Is Trading Higher Today – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Novo Nordisk’s Semaglutide’s Multi-Beneficial Effects: Weight Loss, Improved Metabolic Markers, Liver Fat Reduction in HIV-Related Liver Disease – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Viking Therapeutics’ Weight Loss Study Data Outperformed Novo Nordisk, Eli Lilly Studies, Analysts Say – Viking Therapeutics (NASDAQ:VKTX) Read more
Biotechnology Obesity Solutions Like Weight Loss Drugs To Act As Catalyst For Economic Surge, Goldman Sachs Forecasts – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Global Access to Weight-Loss Treatments: Indian Pharma Giants Eye Affordable Wegovy Alternatives Amid Rising Demand – Novo Nordisk (NYSE:NVO) Read more